Cargando…

Refractory Gastrointestinal Bleeding: Role of Angiographic Intervention

Although endoscopic hemostasis remains initial treatment modality for nonvariceal gastrointestinal (GI) bleeding, severe bleeding despite endoscopic management occurs in 5% to 10% of the patients, requiring surgery or transcatheter arterial embolization (TAE). TAE is now considered the first-line th...

Descripción completa

Detalles Bibliográficos
Autor principal: Shin, Ji Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Gastrointestinal Endoscopy 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797931/
https://www.ncbi.nlm.nih.gov/pubmed/24143308
http://dx.doi.org/10.5946/ce.2013.46.5.486
_version_ 1782287689591029760
author Shin, Ji Hoon
author_facet Shin, Ji Hoon
author_sort Shin, Ji Hoon
collection PubMed
description Although endoscopic hemostasis remains initial treatment modality for nonvariceal gastrointestinal (GI) bleeding, severe bleeding despite endoscopic management occurs in 5% to 10% of the patients, requiring surgery or transcatheter arterial embolization (TAE). TAE is now considered the first-line therapy for massive GI bleeding refractory to endoscopic management. GI endoscopists need to be familiar with indications, principles, outcomes, and complications of TAE, as well as embolic materials available.
format Online
Article
Text
id pubmed-3797931
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Korean Society of Gastrointestinal Endoscopy
record_format MEDLINE/PubMed
spelling pubmed-37979312013-10-18 Refractory Gastrointestinal Bleeding: Role of Angiographic Intervention Shin, Ji Hoon Clin Endosc Special Issue Article of IDEN 2013 Although endoscopic hemostasis remains initial treatment modality for nonvariceal gastrointestinal (GI) bleeding, severe bleeding despite endoscopic management occurs in 5% to 10% of the patients, requiring surgery or transcatheter arterial embolization (TAE). TAE is now considered the first-line therapy for massive GI bleeding refractory to endoscopic management. GI endoscopists need to be familiar with indications, principles, outcomes, and complications of TAE, as well as embolic materials available. The Korean Society of Gastrointestinal Endoscopy 2013-09 2013-09-30 /pmc/articles/PMC3797931/ /pubmed/24143308 http://dx.doi.org/10.5946/ce.2013.46.5.486 Text en Copyright © 2013 Korean Society of Gastrointestinal Endoscopy http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Issue Article of IDEN 2013
Shin, Ji Hoon
Refractory Gastrointestinal Bleeding: Role of Angiographic Intervention
title Refractory Gastrointestinal Bleeding: Role of Angiographic Intervention
title_full Refractory Gastrointestinal Bleeding: Role of Angiographic Intervention
title_fullStr Refractory Gastrointestinal Bleeding: Role of Angiographic Intervention
title_full_unstemmed Refractory Gastrointestinal Bleeding: Role of Angiographic Intervention
title_short Refractory Gastrointestinal Bleeding: Role of Angiographic Intervention
title_sort refractory gastrointestinal bleeding: role of angiographic intervention
topic Special Issue Article of IDEN 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797931/
https://www.ncbi.nlm.nih.gov/pubmed/24143308
http://dx.doi.org/10.5946/ce.2013.46.5.486
work_keys_str_mv AT shinjihoon refractorygastrointestinalbleedingroleofangiographicintervention